Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis

TEL/ETV6 located at chromosome 12p13 encodes a member of the E26 transformation‐specific family of transcription factors. TEL is known to be rearranged in a variety of leukemias and solid tumors resulting in the formation of oncogenic chimeric protein. Tel is essential for maintaining hematopoietic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer science 2009-04, Vol.100 (4), p.689-697
Hauptverfasser: Eguchi‐Ishimae, Minenori, Eguchi, Mariko, Maki, Kazuhiro, Porcher, Catherine, Shimizu, Ritsuko, Yamamoto, Masayuki, Mitani, Kinuko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 697
container_issue 4
container_start_page 689
container_title Cancer science
container_volume 100
creator Eguchi‐Ishimae, Minenori
Eguchi, Mariko
Maki, Kazuhiro
Porcher, Catherine
Shimizu, Ritsuko
Yamamoto, Masayuki
Mitani, Kinuko
description TEL/ETV6 located at chromosome 12p13 encodes a member of the E26 transformation‐specific family of transcription factors. TEL is known to be rearranged in a variety of leukemias and solid tumors resulting in the formation of oncogenic chimeric protein. Tel is essential for maintaining hematopoietic stem cells in the bone marrow. To understand the role of TEL in erythropoiesis, we generated transgenic mice expressing human TEL under the control of Gata1 promoter that is activated during the course of the erythroid‐lineage differentiation (GATA1‐TEL transgenic mice). Although GATA1‐TEL transgenic mice appeared healthy up to 18 months of age, the level of hemoglobin was higher in transgenic mice compared to non‐transgenic littermates. In addition, CD71+/TER119+ and c‐kit+/CD41+ populations proliferated with a higher frequency in transgenic mice when bone marrow cells were cultured in the presence of erythropoietin and thrombopoietin, respectively. In transgenic mice, enhanced expression of Alas‐e and β‐major globin genes was observed in erythroid‐committed cells. When embryonic stem cells expressing human TEL under the same Gata1 promoter were differentiated into hematopoietic cells, immature erythroid precursor increased better compared to controls as judged from the numbers of burst‐forming unit of erythrocytes. Our findings suggest some roles of TEL in expanding erythroid precursors and accumulating hemoglobin. (Cancer Sci 2009; 100: 689–697)
doi_str_mv 10.1111/j.1349-7006.2009.01097.x
format Article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158721</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67254137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6227-b6601364a7c7d8234c079e7ad47805279b217addebcada0a773d0571c80533633</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSNERUvhFZA3sEvqn4ydLBCqRsOPNFIXHdhajnOn4yGJU9-kzOx4BJ6RJ8HpjAa6wxtf63z3-NonSQijGYvrapsxkZepolRmnNIyo4yWKts9Sy5OwvPHWqUlFfw8eYm4pVTIvMxfJOesFJTzQl4k90sYv0PrzO-fvwI0ZoCaDMF0aIPrB-c7sjZ28IGsFsurxeqbJLDrTVcjgbAfNsG7mvQB7BjQByRRITi4dpyckGyg9XeNr1xHcN8NG0CHr5KztWkQXh_3y-Trx8Vq_jld3nz6Mr9eplZyrtJKSsrivEZZVRdc5JaqEpSpc1XQGVdlxVk81VBZUxtqlBI1nSlmoyqEFOIy-XDw7ceqhdpCF9_V6D641oS99sbpp0rnNvrOP-j4wbNCcRYd3h0dgr8fAQfdOrTQNKYDP6KWis9yJlQEiwNog0cMsD7dwuhkx_RWT7noKRc9BaYfA9O72Prm3yn_Nh4TisDbI2DQmmYds7EOT1wcU0gmaeTeH7gfroH9fw-g59e3UyX-ABvZtR0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67254137</pqid></control><display><type>article</type><title>Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis</title><source>Wiley_OA刊</source><creator>Eguchi‐Ishimae, Minenori ; Eguchi, Mariko ; Maki, Kazuhiro ; Porcher, Catherine ; Shimizu, Ritsuko ; Yamamoto, Masayuki ; Mitani, Kinuko</creator><creatorcontrib>Eguchi‐Ishimae, Minenori ; Eguchi, Mariko ; Maki, Kazuhiro ; Porcher, Catherine ; Shimizu, Ritsuko ; Yamamoto, Masayuki ; Mitani, Kinuko</creatorcontrib><description>TEL/ETV6 located at chromosome 12p13 encodes a member of the E26 transformation‐specific family of transcription factors. TEL is known to be rearranged in a variety of leukemias and solid tumors resulting in the formation of oncogenic chimeric protein. Tel is essential for maintaining hematopoietic stem cells in the bone marrow. To understand the role of TEL in erythropoiesis, we generated transgenic mice expressing human TEL under the control of Gata1 promoter that is activated during the course of the erythroid‐lineage differentiation (GATA1‐TEL transgenic mice). Although GATA1‐TEL transgenic mice appeared healthy up to 18 months of age, the level of hemoglobin was higher in transgenic mice compared to non‐transgenic littermates. In addition, CD71+/TER119+ and c‐kit+/CD41+ populations proliferated with a higher frequency in transgenic mice when bone marrow cells were cultured in the presence of erythropoietin and thrombopoietin, respectively. In transgenic mice, enhanced expression of Alas‐e and β‐major globin genes was observed in erythroid‐committed cells. When embryonic stem cells expressing human TEL under the same Gata1 promoter were differentiated into hematopoietic cells, immature erythroid precursor increased better compared to controls as judged from the numbers of burst‐forming unit of erythrocytes. Our findings suggest some roles of TEL in expanding erythroid precursors and accumulating hemoglobin. (Cancer Sci 2009; 100: 689–697)</description><identifier>ISSN: 1347-9032</identifier><identifier>ISSN: 1349-7006</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/j.1349-7006.2009.01097.x</identifier><identifier>PMID: 19302286</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Animals ; Biological and medical sciences ; Erythroid Precursor Cells - cytology ; Erythroid Precursor Cells - metabolism ; Erythropoiesis - genetics ; ETS Translocation Variant 6 Protein ; GATA1 Transcription Factor - genetics ; Hematologic and hematopoietic diseases ; Hemoglobins - biosynthesis ; Humans ; Leukemia - genetics ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Mice ; Mice, Transgenic ; Original ; Promoter Regions, Genetic ; Proto-Oncogene Proteins c-ets - genetics ; Repressor Proteins - genetics ; Tumors</subject><ispartof>Cancer science, 2009-04, Vol.100 (4), p.689-697</ispartof><rights>2009 Japanese Cancer Association</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6227-b6601364a7c7d8234c079e7ad47805279b217addebcada0a773d0571c80533633</citedby><cites>FETCH-LOGICAL-c6227-b6601364a7c7d8234c079e7ad47805279b217addebcada0a773d0571c80533633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11158721/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11158721/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1349-7006.2009.01097.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21336160$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19302286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eguchi‐Ishimae, Minenori</creatorcontrib><creatorcontrib>Eguchi, Mariko</creatorcontrib><creatorcontrib>Maki, Kazuhiro</creatorcontrib><creatorcontrib>Porcher, Catherine</creatorcontrib><creatorcontrib>Shimizu, Ritsuko</creatorcontrib><creatorcontrib>Yamamoto, Masayuki</creatorcontrib><creatorcontrib>Mitani, Kinuko</creatorcontrib><title>Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>TEL/ETV6 located at chromosome 12p13 encodes a member of the E26 transformation‐specific family of transcription factors. TEL is known to be rearranged in a variety of leukemias and solid tumors resulting in the formation of oncogenic chimeric protein. Tel is essential for maintaining hematopoietic stem cells in the bone marrow. To understand the role of TEL in erythropoiesis, we generated transgenic mice expressing human TEL under the control of Gata1 promoter that is activated during the course of the erythroid‐lineage differentiation (GATA1‐TEL transgenic mice). Although GATA1‐TEL transgenic mice appeared healthy up to 18 months of age, the level of hemoglobin was higher in transgenic mice compared to non‐transgenic littermates. In addition, CD71+/TER119+ and c‐kit+/CD41+ populations proliferated with a higher frequency in transgenic mice when bone marrow cells were cultured in the presence of erythropoietin and thrombopoietin, respectively. In transgenic mice, enhanced expression of Alas‐e and β‐major globin genes was observed in erythroid‐committed cells. When embryonic stem cells expressing human TEL under the same Gata1 promoter were differentiated into hematopoietic cells, immature erythroid precursor increased better compared to controls as judged from the numbers of burst‐forming unit of erythrocytes. Our findings suggest some roles of TEL in expanding erythroid precursors and accumulating hemoglobin. (Cancer Sci 2009; 100: 689–697)</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Erythroid Precursor Cells - cytology</subject><subject>Erythroid Precursor Cells - metabolism</subject><subject>Erythropoiesis - genetics</subject><subject>ETS Translocation Variant 6 Protein</subject><subject>GATA1 Transcription Factor - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemoglobins - biosynthesis</subject><subject>Humans</subject><subject>Leukemia - genetics</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Original</subject><subject>Promoter Regions, Genetic</subject><subject>Proto-Oncogene Proteins c-ets - genetics</subject><subject>Repressor Proteins - genetics</subject><subject>Tumors</subject><issn>1347-9032</issn><issn>1349-7006</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhSNERUvhFZA3sEvqn4ydLBCqRsOPNFIXHdhajnOn4yGJU9-kzOx4BJ6RJ8HpjAa6wxtf63z3-NonSQijGYvrapsxkZepolRmnNIyo4yWKts9Sy5OwvPHWqUlFfw8eYm4pVTIvMxfJOesFJTzQl4k90sYv0PrzO-fvwI0ZoCaDMF0aIPrB-c7sjZ28IGsFsurxeqbJLDrTVcjgbAfNsG7mvQB7BjQByRRITi4dpyckGyg9XeNr1xHcN8NG0CHr5KztWkQXh_3y-Trx8Vq_jld3nz6Mr9eplZyrtJKSsrivEZZVRdc5JaqEpSpc1XQGVdlxVk81VBZUxtqlBI1nSlmoyqEFOIy-XDw7ceqhdpCF9_V6D641oS99sbpp0rnNvrOP-j4wbNCcRYd3h0dgr8fAQfdOrTQNKYDP6KWis9yJlQEiwNog0cMsD7dwuhkx_RWT7noKRc9BaYfA9O72Prm3yn_Nh4TisDbI2DQmmYds7EOT1wcU0gmaeTeH7gfroH9fw-g59e3UyX-ABvZtR0</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Eguchi‐Ishimae, Minenori</creator><creator>Eguchi, Mariko</creator><creator>Maki, Kazuhiro</creator><creator>Porcher, Catherine</creator><creator>Shimizu, Ritsuko</creator><creator>Yamamoto, Masayuki</creator><creator>Mitani, Kinuko</creator><general>Blackwell Publishing Asia</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200904</creationdate><title>Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis</title><author>Eguchi‐Ishimae, Minenori ; Eguchi, Mariko ; Maki, Kazuhiro ; Porcher, Catherine ; Shimizu, Ritsuko ; Yamamoto, Masayuki ; Mitani, Kinuko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6227-b6601364a7c7d8234c079e7ad47805279b217addebcada0a773d0571c80533633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Erythroid Precursor Cells - cytology</topic><topic>Erythroid Precursor Cells - metabolism</topic><topic>Erythropoiesis - genetics</topic><topic>ETS Translocation Variant 6 Protein</topic><topic>GATA1 Transcription Factor - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemoglobins - biosynthesis</topic><topic>Humans</topic><topic>Leukemia - genetics</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Original</topic><topic>Promoter Regions, Genetic</topic><topic>Proto-Oncogene Proteins c-ets - genetics</topic><topic>Repressor Proteins - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eguchi‐Ishimae, Minenori</creatorcontrib><creatorcontrib>Eguchi, Mariko</creatorcontrib><creatorcontrib>Maki, Kazuhiro</creatorcontrib><creatorcontrib>Porcher, Catherine</creatorcontrib><creatorcontrib>Shimizu, Ritsuko</creatorcontrib><creatorcontrib>Yamamoto, Masayuki</creatorcontrib><creatorcontrib>Mitani, Kinuko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Eguchi‐Ishimae, Minenori</au><au>Eguchi, Mariko</au><au>Maki, Kazuhiro</au><au>Porcher, Catherine</au><au>Shimizu, Ritsuko</au><au>Yamamoto, Masayuki</au><au>Mitani, Kinuko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2009-04</date><risdate>2009</risdate><volume>100</volume><issue>4</issue><spage>689</spage><epage>697</epage><pages>689-697</pages><issn>1347-9032</issn><issn>1349-7006</issn><eissn>1349-7006</eissn><abstract>TEL/ETV6 located at chromosome 12p13 encodes a member of the E26 transformation‐specific family of transcription factors. TEL is known to be rearranged in a variety of leukemias and solid tumors resulting in the formation of oncogenic chimeric protein. Tel is essential for maintaining hematopoietic stem cells in the bone marrow. To understand the role of TEL in erythropoiesis, we generated transgenic mice expressing human TEL under the control of Gata1 promoter that is activated during the course of the erythroid‐lineage differentiation (GATA1‐TEL transgenic mice). Although GATA1‐TEL transgenic mice appeared healthy up to 18 months of age, the level of hemoglobin was higher in transgenic mice compared to non‐transgenic littermates. In addition, CD71+/TER119+ and c‐kit+/CD41+ populations proliferated with a higher frequency in transgenic mice when bone marrow cells were cultured in the presence of erythropoietin and thrombopoietin, respectively. In transgenic mice, enhanced expression of Alas‐e and β‐major globin genes was observed in erythroid‐committed cells. When embryonic stem cells expressing human TEL under the same Gata1 promoter were differentiated into hematopoietic cells, immature erythroid precursor increased better compared to controls as judged from the numbers of burst‐forming unit of erythrocytes. Our findings suggest some roles of TEL in expanding erythroid precursors and accumulating hemoglobin. (Cancer Sci 2009; 100: 689–697)</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19302286</pmid><doi>10.1111/j.1349-7006.2009.01097.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1347-9032
ispartof Cancer science, 2009-04, Vol.100 (4), p.689-697
issn 1347-9032
1349-7006
1349-7006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11158721
source Wiley_OA刊
subjects Animals
Biological and medical sciences
Erythroid Precursor Cells - cytology
Erythroid Precursor Cells - metabolism
Erythropoiesis - genetics
ETS Translocation Variant 6 Protein
GATA1 Transcription Factor - genetics
Hematologic and hematopoietic diseases
Hemoglobins - biosynthesis
Humans
Leukemia - genetics
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Mice
Mice, Transgenic
Original
Promoter Regions, Genetic
Proto-Oncogene Proteins c-ets - genetics
Repressor Proteins - genetics
Tumors
title Leukemia‐related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A21%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukemia%E2%80%90related%20transcription%20factor%20TEL/ETV6%20expands%20erythroid%20precursors%20and%20stimulates%20hemoglobin%20synthesis&rft.jtitle=Cancer%20science&rft.au=Eguchi%E2%80%90Ishimae,%20Minenori&rft.date=2009-04&rft.volume=100&rft.issue=4&rft.spage=689&rft.epage=697&rft.pages=689-697&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/j.1349-7006.2009.01097.x&rft_dat=%3Cproquest_24P%3E67254137%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67254137&rft_id=info:pmid/19302286&rfr_iscdi=true